The rise of electronic health records can facilitate the use of decision support systems when ordering and selecting imaging tests. Also, should these tools be mandated?
The rise of electronic health records can facilitate the use of decision support systems when ordering and selecting imaging tests.
That’s according to Steven Seltzer, MD, chairman of the department of radiology at Brigham and Women’s Hospital, who spoke Thursday at The Summit on Management of Radiation Dose in Computerized Tomography at the National Institutes of Health.
EHRs, the use of which is growing thanks to the federal government’s program to offer incentives for EHR adoption, can provide an easy support system for physicians - based on medical evidence and appropriateness data.
“Without an electronic health record, we don’t have this, but now that we’re getting them… we will soon have these tools,” Seltzer said at the summit, which was videocast online. The two-day summit aims to bring together the imaging community to identify steps and research needed to reduce CT exam dose to less than one mSv.
Decision support systems are being explored as tools to reduce unnecessary tests and exposure, and CMS’ two-year Medicare Imaging Demonstration project recently launched to see if the systems are effective.
Using the decision support connected to the EHR can reduce errors, optimize reimbursement by connecting the tests with billing codes, and facilitate the transfer of clinical data and results, Seltzer said.
“All of these things become possible when you move out of the analog era,” he said.
Hedvig Hricak, MD, PhD, chair of the department of radiology at Memorial Sloan-Kettering Cancer Center in New York City and professor of radiology at Cornell University Medical College, argued in her earlier presentation Thursday that decision support tools should be mandatory. It’s time to regulate, she said.
“It should be in every practice,” she said. The problem with computerized decision support systems, she noted, was they must be developed in a multidisciplinary setting, which can be complicated.
“The problem is you’re going to have a relatively easier time implementing them in larger tertiary centers and academic settings, but where it makes a bigger difference is in the community setting and every private physician in this country.”
Decision support was also among the strategies for reducing radiation exposire outlined at the summit by representatives from the American College of Radiology. The group also pointed to ACR accreditation, including basic training and image standards, and a dose index registry, which collects patient dose information and compares against national benchmarks.
"Accreditation, decision support systems and the CT dose registry programs can reduce adverse events, unwarranted radiation exposure and unnecessary cost if Congress would vote to require all imaging providers - including hospitals - to participate in them," John A. Patti, MD, FACR, chair of the ACR Board of Chancellors said in a statement. "Now, when imaging providers and government agencies are coming together to arrive at better imaging policy is the time for Congress to act to require participation in these programs and help ensure quality and safety of medical imaging care."
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.